TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataKi: 96nMAssay Description:Competitive inhibition of MK2 ATP-binding siteMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataKi: 310nMAssay Description:Uncompetitive inhibition of MK2 ATP-binding siteMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataKi: 320nMAssay Description:Mixed inhibition of MK2 ATP-binding siteMore data for this Ligand-Target Pair
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataKi: 480nMAssay Description:Noncompetitive inhibition of MK2 ATP-binding siteMore data for this Ligand-Target Pair
Affinity DataIC50: 2.40nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 2.51nMAssay Description:Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp methodMore data for this Ligand-Target Pair
Affinity DataIC50: 2.63nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 2.63nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 2.82nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 4.90nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 5.62nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 6.46nMAssay Description:Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp methodMore data for this Ligand-Target Pair
Affinity DataIC50: 6.61nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 8.13nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 11.5nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 12nMAssay Description:Antagonist activity at CCR8 receptorMore data for this Ligand-Target Pair
Affinity DataIC50: 12nMAssay Description:Antagonist activity at CCR8 receptorMore data for this Ligand-Target Pair
Affinity DataIC50: 14.8nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 16nMAssay Description:Antagonist activity at CCR8 receptorMore data for this Ligand-Target Pair
Affinity DataIC50: 17.4nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:Antagonist activity at CCR8 receptorMore data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:Antagonist activity at CCR8 receptorMore data for this Ligand-Target Pair
Affinity DataIC50: 19.1nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 22.4nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 22.4nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 25nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
Affinity DataIC50: 27nMAssay Description:Antagonist activity at CCR8 receptorMore data for this Ligand-Target Pair
Affinity DataIC50: 27.5nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 28nMAssay Description:Antagonist activity at CCR8 receptorMore data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:Compound was tested for inhibition of osteoclast vacuolar ATPase derived from chicken medullary boneMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 30.2nMAssay Description:Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp methodMore data for this Ligand-Target Pair
Affinity DataIC50: 30.9nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 32.4nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 33nMAssay Description:Antagonist activity at CCR8 receptorMore data for this Ligand-Target Pair
Affinity DataIC50: 33nMAssay Description:Antagonist activity at CCR8 receptorMore data for this Ligand-Target Pair
Affinity DataIC50: 34.7nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 35nMAssay Description:Antagonist activity at CCR8 receptorMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 45.7nMAssay Description:Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiologyMore data for this Ligand-Target Pair
Affinity DataIC50: 49nMAssay Description:Compound was tested for inhibition of osteoclast vacuolar ATPase derived from chicken medullary boneMore data for this Ligand-Target Pair
Affinity DataIC50: 55.0nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
Affinity DataIC50: 56nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
Affinity DataIC50: 70.8nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 70.8nMAssay Description:Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiologyMore data for this Ligand-Target Pair
Affinity DataIC50: 79nMAssay Description:Antagonist activity at CCR8 receptorMore data for this Ligand-Target Pair
Affinity DataIC50: 81nMAssay Description:Antagonist activity at CCR8 receptorMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 81.3nMAssay Description:Displacement of [3H]dofetilide from human recombinant ERG expressed in HEK293 cells by patch clamp methodMore data for this Ligand-Target Pair
Affinity DataIC50: 81.3nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 83.2nMAssay Description:Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiologyMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca
Curated by ChEMBL
Astrazeneca
Curated by ChEMBL
Affinity DataIC50: 87.1nMAssay Description:Inhibition of wild type human ERG expressed in CHOK1 cells by whole-cell plate-based electrophysiologyMore data for this Ligand-Target Pair
Affinity DataIC50: 95.5nMAssay Description:Antagonist activity at human CCR8More data for this Ligand-Target Pair